Skip to main content
67°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about INCY
Recent news which mentions INCY
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Approval Of Baricitinib For Patchy Baldness Validates Clinical Patch For This Small-Cap Stock
June 14, 2022
Tickers
EQ
INCY
LLY
Tags
General
Analyst Ratings
Price Target
From
Benzinga
The Daily Biotech Pulse: FDA Nod For Lilly-Incyte's Patchy Hair Loss Treatment, First Regulatory Submission For EQRx, Soleno's Promising Data From Prader-Willi Candidate
June 14, 2022
Tickers
ALNY
DAWN
EQRX
FRLN
Tags
NGM
Trading Ideas
DAWN
From
Benzinga
Morning Brief: Top Financial Stories Dominating on Tuesday, June 14
June 14, 2022
Tickers
AAPL
AFLYY
AMZN
BRK-B
Tags
META
Market News
BRK/B
From
Benzinga
Lilly-Incyte Snag FDA Nod For Patchy Hair Loss Treatment — Smaller Rival's Stock Shoots Up In Sympathy
June 14, 2022
Tickers
CNCE
INCY
LLY
PFE
Tags
Olumiant
Biotech
Penny Stocks
From
Benzinga
In a shaky economy, cash is king — and these S&P 500 companies have it, says Barclays
June 09, 2022
Tickers
AAPL
AKAM
AMZN
ATVI
Tags
LYV
NFLX
AMZN
From
MarketWatch
CHMP Backs Approval of Lilly/Incyte's Olumiant For Patchy Hair Loss
May 20, 2022
Tickers
INCY
LLY
Tags
Large Cap
General
Benzinga
From
Benzinga
2 Under-the-Radar Biotech Stocks to Buy in 2022
May 18, 2022
Tickers
AXSM
INCY
JAZZ
NVS
Tags
NVS
INCY
Recent Press Releases
From
Motley Fool
Was This Acquisition a Smart Move for GlaxoSmithKline?
May 14, 2022
Tickers
GSK
INCY
SRRA
Tags
SRRA
Market News
GSK
From
Motley Fool
Mizuho Sees Relief For This Small-Cap Stock After Patent Legal Overhang Lifted
May 13, 2022
Tickers
CNCE
INCY
Tags
General
Analyst Ratings
Legal
From
Benzinga
Why CTI Biopharma Stock Is Surging Today
May 13, 2022
Tickers
CTIC
INCY
Tags
INCY
Recent Press Releases
Market News
From
Motley Fool
Amid Slowing Sales at Home, Innovent Biologics Stumbles Overseas
May 13, 2022
Tickers
ASIA
BGNE
CHRS
HCM
Tags
Small Cap
HCM
Asia
From
Benzinga
WHO head censored in China after criticizing zero-COVID policy, and U.S. cases up 52% from two weeks ago
May 11, 2022
Tickers
EBS
INCY
LLY
MSFT
Tags
MSFT
EBS
LLY
From
MarketWatch
FDA Approves Lilly and Incyte's OLUMIANT (baricitinib) for Hospitalized Patients with COVID-19
May 11, 2022
Tickers
INCY
LLY
Tags
Biotech
General
INCY
From
Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
May 05, 2022
Tickers
ABUS
AGIO
ALDX
ARGX
Tags
General
PRTA
NVS
From
Benzinga
4 Analysts Have This to Say About Incyte
May 04, 2022
Tickers
INCY
Tags
INCY
BZI/AAR
Benzinga
From
Benzinga
Despite Q1 Earnings Miss, Incyte Shares Jump On Revised FY22 Sales Guidance
May 03, 2022
Tickers
INCY
Tags
General
Market News
Guidance
From
Benzinga
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
May 03, 2022
Tickers
ACAD
AQST
BIIB
BLTE
Tags
CRTX
SESN
LTRN
From
Benzinga
Incyte: Q1 Earnings Insights
May 03, 2022
Tickers
INCY
Tags
Benzinga
INCY
BZI/Recaps
From
Benzinga
Global Cord Blood Enters Therapy Market Via Cellenkos Acquisition For Over $600M
May 02, 2022
Tickers
CO
INCY
Tags
INCY
Benzinga
Biotech
From
Benzinga
The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More
May 02, 2022
Tickers
AGTC
AMGN
AMRN
ATHX
Tags
Small Cap
Earnings
ATHX
From
Benzinga
3 Nasdaq Stocks to Buy Now for Growth
May 01, 2022
Tickers
AMZN
AVGO
BLK
FTXL
Tags
INCY
INTC
ROKU
From
InvestorPlace
EMA's Advisory Committee Backs Approval Of Incyte's Capmatinib In Advanced Lung Cancer Setting
April 22, 2022
Tickers
INCY
NVS
Tags
Large Cap
European Medicines Agency
General
From
Benzinga
How To Attend Incyte Q1 2022 Earnings Conference Call
April 21, 2022
Tickers
INCY
Tags
Market News
BZI/CONF
INCY
From
Benzinga
The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy
April 06, 2022
Tickers
BGNE
BTAI
CCCC
CTXR
Tags
Penny Stocks
RLMD
SRRK
From
Benzinga
This Favorable Sign Appears On Incyte's Chart
April 05, 2022
Tickers
INCY
Tags
Trading Ideas
Movers
Market News
From
Benzinga
Incyte's Ruxolitinib Shows Further Improvement In Facial, Total Body Re-pigmentation At 52 Weeks In Skin Disorder
March 28, 2022
Tickers
INCY
Tags
Health Care
Market News
News
From
Benzinga
Incyte-Lilly's Olumiant Continue To Show Improved Scalp, Eyebrows, Eyelash Hair Regrowth At 52 Weeks
March 28, 2022
Tickers
INCY
LLY
Tags
Briefs
Biotech
General
From
Benzinga
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
March 24, 2022
Tickers
INCY
NVO
NVS
Tags
Market News
NVS
INCY
From
Motley Fool
The Daily Biotech Pulse: Pfizer Reports Positive Ulcerative Colitis Study Data, Novavax COVID Shot Authorized For Adolescents In India, Argenx Stock Sale
March 23, 2022
Tickers
APTO
APTX
ARGX
BMY
Tags
CLBS
Biotech
APTX
From
Benzinga
MorphoSys-Incyte Partnered Minjuvi Temporarily Approved In Switzerland
March 23, 2022
Tickers
INCY
MOR
Tags
Health Care
Market News
News
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.